title: Rituximab (anti-CD20 monoclonal antibody)--ultimate or first choice in pemphigus?
authors: Michael
authors: M
authors: Hertl
authors: Rüdiger
authors: R
authors: Eming
authors: Luca
authors: L
authors: Borradori
mesh_terms: D000911:Antibodies, Monoclonal / Q000494:pharmacology / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D001402:B-Lymphocytes / Q000187:drug effects / Q000276:immunology; D006801:Humans; D007155:Immunologic Factors / Q000494:pharmacology / Q000627:therapeutic use*; D010392:Pemphigus / Q000188:drug therapy* / Q000276:immunology; D000069283:Rituximab
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D000069283:Rituximab